Natco Pharma updates on Risdiplam launch in India, Delhi High Court denies Roche's injunction plea, pricing set at ₹15,900.

Natco Pharma on Tuesday shared a legal update on the legal proceedings on the Risdiplam compound (used for treating spinal ...

The company said it has decided to price its version of Risdiplam product at Rs 15,900, and further added that it intends to ...

Natco Pharma plans to launch generic Risdiplam pending Delhi High Court decision, offering discounts to patients.

Natco Pharma Limited is a vertically integrated and R&D focused pharmaceutical company that specialises in development, manufacturing and marketing of Finished Dosage Formulations (FDF ...

The drug enhances the flow of blood through the lungs, allowing children with PAH to breathe and improve their ability to engage in physical activity. According to data from the BSE index, the ...

Telangana: Natco Pharma has announced the superannuation of Dr Ramesh Dandala, Executive Vice President - Technology Transfer ...

The bench said that public good outweighs the company’s profit as the drug is not available at an affordable price in India.

Format of Initial Disclosure to be made by an entity identified as a Large Corporate.<br/><br/> <table border='&ap ...

Natco Pharma has announced the supperannuation of Tummala Venkata Rao, Vice President - Production of the Company."With ...